Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Green

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Biological Research for Nursing|December 8, 2004
Exploration of the contribution of biobehavioral variables to the energy expenditure of preterm infantsKaren Pridham, Abhik Bhattacharya, Suzanne Thoyre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid ArthritisAdam P Cribbs, Alan Kennedy, Henry Penn, et al.
Cardiovascular Research|May 5, 2018
Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversityJennifer E Cole, Inhye Park, David J Ahern, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2011
Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cellsPaul A Beavis, Bernard Gregory, Patricia Green, et al.
European Journal of Immunology|July 22, 2014
A novel upstream enhancer of FOXP3, sensitive to methylation-induced silencing, exhibits dysregulated methylation in rheumatoid arthritis Treg cellsAlan Kennedy, Emily M Schmidt, Adam P Cribbs, et al.
Psychotherapy (Chicago, Ill.)|September 12, 2012
Supportive-expressive dynamic psychotherapy in the community mental health system: a pilot effectiveness trial for the treatment of depressionMary Beth Connolly Gibbons, Sarah M Thompson, Kelli Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug developmentJennifer E Cole, Nagore Astola, Adam P Cribbs, et al.
Plos One|October 25, 2024
Internal evaluation of medical programs is more than housework: A scoping reviewSujani Kodagoda Gamage, Tanisha Jowsey, Jo Bishop, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 4, 2014
Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathwayAdam P Cribbs, Alan Kennedy, Henry Penn, et al.
Arthritis Research & Therapy|March 21, 2008
Resting CD4+ effector memory T cells are precursors of bystander-activated effectors: a surrogate model of rheumatoid arthritis synovial T-cell functionFionula M Brennan, Nicola M G Smith, Sally Owen, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Biological Research for Nursing|December 8, 2004
Exploration of the contribution of biobehavioral variables to the energy expenditure of preterm infantsKaren Pridham, Abhik Bhattacharya, Suzanne Thoyre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid ArthritisAdam P Cribbs, Alan Kennedy, Henry Penn, et al.
Cardiovascular Research|May 5, 2018
Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversityJennifer E Cole, Inhye Park, David J Ahern, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2011
Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cellsPaul A Beavis, Bernard Gregory, Patricia Green, et al.
European Journal of Immunology|July 22, 2014
A novel upstream enhancer of FOXP3, sensitive to methylation-induced silencing, exhibits dysregulated methylation in rheumatoid arthritis Treg cellsAlan Kennedy, Emily M Schmidt, Adam P Cribbs, et al.
Psychotherapy (Chicago, Ill.)|September 12, 2012
Supportive-expressive dynamic psychotherapy in the community mental health system: a pilot effectiveness trial for the treatment of depressionMary Beth Connolly Gibbons, Sarah M Thompson, Kelli Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug developmentJennifer E Cole, Nagore Astola, Adam P Cribbs, et al.
Plos One|October 25, 2024
Internal evaluation of medical programs is more than housework: A scoping reviewSujani Kodagoda Gamage, Tanisha Jowsey, Jo Bishop, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 4, 2014
Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathwayAdam P Cribbs, Alan Kennedy, Henry Penn, et al.
Arthritis Research & Therapy|March 21, 2008
Resting CD4+ effector memory T cells are precursors of bystander-activated effectors: a surrogate model of rheumatoid arthritis synovial T-cell functionFionula M Brennan, Nicola M G Smith, Sally Owen, et al.
Pageof 4